Association of Noninvasively Measured Left Ventricular Mechanics With In Vitro Muscle Contractile Performance: A Prospective Study in Hypertrophic Cardiomyopathy Patients

BACKGROUND Hypertrophic cardiomyopathy (HCM) is a primary myopathic process in which regional left ventricular dysfunction may exist without overt global left ventricular dysfunction. In obstructive HCM patients who underwent surgical myectomy (SM), we sought to determine if there is a significant association between echocardiographic longitudinal strain, histopathology, and in vitro myocardial performance (resting tension and developed tension) of the surgical specimen. METHODS AND RESULTS HCM patients (n=122, 54±14 years, 54% men) undergoing SM were prospectively recruited. Longitudinal systolic strain and diastolic strain rates were measured at that basal septum (partially removed at SM) by using velocity vector imaging on preoperative echocardiography. Semiquantitative histopathologic grading of myocyte disarray and fibrosis and in vitro measurements of resting tension and developed tension were made in septal tissue obtained at SM. Mean basal septal systolic strain and diastolic strain rate were -8.3±5% and 0.62±0.4/s, while mild or greater degree of myocyte disarray and interstitial fibrosis were present in 85% and 87%, respectively. Mean resting tension and developed tension were 2.8±1 and 1.4±0.8 g/mm(2). On regression analysis, basal septal systolic strain, diastolic strain rate, disarray, and fibrosis were associated with developed tension (β=0.19, 0.20, -0.33, and -0.40, respectively, all P<0.01) and resting tension (β=0.21, 0.22, -0.25, and -0.28, respectively, all P<0.01). CONCLUSION In obstructive HCM patients who underwent SM, left ventricular mechanics (echocardiographic longitudinal systolic strain and diastolic strain rates), assessed at the basal septum (myocardium removed during myectomy) and histopathologic findings characteristic for HCM (disarray and fibrosis) were significantly associated with in vitro myocardial resting and developed contractile performance.

[1]  W. Roberts,et al.  Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. , 2000, Journal of the American College of Cardiology.

[2]  A. McCulloch,et al.  Regional dysfunction correlates with myofiber disarray in transgenic mice with ventricular expression of ras. , 2000, American journal of physiology. Heart and circulatory physiology.

[3]  A. Neskovic,et al.  Myocardial fibrosis assessment by semiquantitative, point‐counting and computer‐based methods in patients with heart muscle disease: a comparative study , 2001, Histopathology.

[4]  W. Roberts,et al.  Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.

[5]  W J McKenna,et al.  Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. , 2001, The American journal of cardiology.

[6]  Yang Yu,et al.  Left and right ventricular strain and strain rate measurement in normal adults using velocity vector imaging: an assessment of reference values and intersystem agreement , 2013, The International Journal of Cardiovascular Imaging.

[7]  K. R. Anderson,et al.  Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. , 1980, British heart journal.

[8]  Mario J. Garcia,et al.  Doppler-Derived Myocardial Systolic Strain Rate Is a Strong Index of Left Ventricular Contractility , 2002, Circulation.

[9]  Victor Mor-Avi,et al.  Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[10]  J. Sprung,et al.  The Effects of Etomidate on the Contractility of Failing and Nonfailing Human Heart Muscle , 2000, Anesthesia and analgesia.

[11]  Michael Becker,et al.  Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range. , 2009, JACC. Cardiovascular imaging.

[12]  F. Flachskampf,et al.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[13]  S. Colan,et al.  Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. , 2010, The New England journal of medicine.

[14]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[15]  B. Maron,et al.  Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. , 1999, JAMA.

[16]  F. Crea,et al.  Coronary microvascular dysfunction. , 2013, The New England journal of medicine.

[17]  Barry J Maron,et al.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, The Journal of thoracic and cardiovascular surgery.

[18]  E. Olsen,et al.  Pathology of hypertrophic cardiomyopathy. , 1986, Postgraduate medical journal.

[19]  W. Roberts,et al.  Morphologic evidence for "small vessel disease" in patients with hypertrophic cardiomyopathy. , 1987, Zeitschrift fur Kardiologie.

[20]  N. Smedira,et al.  Predictors of Long-Term Outcomes in Symptomatic Hypertrophic Obstructive Cardiomyopathy Patients Undergoing Surgical Relief of Left Ventricular Outflow Tract Obstruction , 2013, Circulation.

[21]  Z. Krajcer,et al.  Coronary artery disease in hypertrophic cardiomyopathy. , 1985, The American journal of cardiology.

[22]  H. Rakowski,et al.  Diastolic myocardial mechanics in hypertrophic cardiomyopathy. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[23]  W. Mckenna,et al.  Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity , 2002, Heart.

[24]  M. Cheitlin,et al.  Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy , 2011 .

[25]  M. Quiñones,et al.  Tissue Doppler Imaging Predicts the Development of Hypertrophic Cardiomyopathy in Subjects With Subclinical Disease , 2003, Circulation.

[26]  D. Khoury,et al.  Impact of myocardial structure and function postinfarction on diastolic strain measurements: implications for assessment of myocardial viability. , 2006, American journal of physiology. Heart and circulatory physiology.

[27]  Scott D Flamm,et al.  Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[29]  J. Sprung,et al.  Effects of remifentanil on the contractility of failing human heart muscle. , 2005, Journal of cardiothoracic and vascular anesthesia.

[30]  N. Smedira,et al.  Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. , 2008, The Annals of thoracic surgery.

[31]  R. Levine,et al.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[32]  N. Smedira,et al.  Association between septal strain rate and histopathology in symptomatic hypertrophic cardiomyopathy patients undergoing septal myectomy. , 2013, American heart journal.

[33]  Shemy Carasso,et al.  Systolic myocardial mechanics in hypertrophic cardiomyopathy: novel concepts and implications for clinical status. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[34]  M. Sheppard,et al.  Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .

[35]  Y. Duan,et al.  Velocity vector imaging in assessing myocardial systolic function of hypertensive patients with left ventricular hypertrophy. , 2007, The Canadian journal of cardiology.

[36]  Y. Duan,et al.  Velocity Vector Imaging in Assessing the Regional Systolic Function of Patients with Post Myocardial Infarction , 2007, Echocardiography.

[37]  A. DeMaria,et al.  Assessment of diastolic function with Doppler tissue imaging after cardiac surgery: effect of the "postoperative septum" in on-pump and off-pump procedures. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[38]  Neil L Greenberg,et al.  Speckle-tracking echocardiography correctly identifies segmental left ventricular dysfunction induced by scarring in a rat model of myocardial infarction. , 2007, American journal of physiology. Heart and circulatory physiology.

[39]  J. Thomas,et al.  Resting echocardiographic features of latent left ventricular outflow obstruction in hypertrophic cardiomyopathy. , 1996, The American journal of cardiology.

[40]  W J McKenna,et al.  Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease , 2000, Heart.

[41]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[42]  N. Smedira,et al.  Mechanical Unloading Restores &bgr;-Adrenergic Responsiveness and Reverses Receptor Downregulation in the Failing Human Heart , 2001, Circulation.

[43]  P. Elliott,et al.  Hypertrophic Cardiomyopathy: Histopathological Features of Sudden Death in Cardiac Troponin T Disease , 2001, Circulation.